Russell Frank Company’s AMAG Pharmaceuticals AMAG Stock Holding History

Russell Frank Company’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$5.11M	Buy	218,534 +40,792	+23%	+$968K	0.01%	1313
2015 Q4	$5.42M	Sell	177,742 -48,273	-21%	-$1.56M	0.01%	1239
2015 Q3	$8.98M	Buy	226,015 +19,284	+9%	+$1.2M	0.02%	945
2015 Q2	$14.3M	Buy	206,731 +155,228	+301%	+$9.77M	0.02%	794
2015 Q1	$2.81M	Sell	51,503 -7,673	-13%	-$366K	0.01%	1576
2014 Q4	$2.55M	Sell	59,176 -4,747	-7%	-$172K	﹤0.01%	1640
2014 Q3	$2.04M	Buy	+63,923	New	+$1.36M	﹤0.01%	1726
2014 Q1	–	Sell	-61,221	Closed	-$1.41M	–	2904
2013 Q4	$1.41M	Buy	61,221 +12,566	+26%	+$296K	﹤0.01%	1912
2013 Q3	$1.04M	Sell	48,655 -3,421	-7%	-$80.8K	﹤0.01%	2156
2013 Q2	$1.16M	Buy	+52,076	New	+$1.15M	﹤0.01%	2000

Other funds holding AMAG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIM

Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return

Russell Frank Company's AMAG Position: Q1 2016 in Review

Russell Frank Company increased its AMAG Pharmaceuticals (AMAG) stake by 23% in Q1 2016, buying an estimated $968K and bringing the position to 218,534 shares worth $5.11M. The position accounts for 0.01% of the portfolio, ranked #1313.

Russell Frank Company first reported a position in AMAG in Q2 2013 and has held it in 10 quarters since. The position peaked at $14.3M in Q2 2015. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2016.

Russell Frank Company held 218,534 shares of AMAG Pharmaceuticals worth $5.11M as of Q1 2016.
Russell Frank Company bought 40,792 AMAG Pharmaceuticals shares in Q1 2016, an estimated $968K.
AMAG Pharmaceuticals made up 0.01% of Russell Frank Company's portfolio in Q1 2016, its #1313 holding.
Russell Frank Company first reported a position in AMAG Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
Russell Frank Company's AMAG Pharmaceuticals position peaked at $14.3M in Q2 2015.
185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.